NJ Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 135

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $10M

NJ Bio General Information

Description

Operator of a biotechnology and pharmaceutical contracting company intended to provide integrated chemistry and biology services. The company provides services such as multistep organic synthesis, medicinal chemistry, bioconjugation, antibody-drug conjugates and flow chemistry, enabling clients to accelerate their product development programs and research needs.

Contact Information

Website
www.njbio.com
Formerly Known As
NJ Biopharmaceuticals
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 350 Carter Road
  • Princeton, NJ 08540
  • United States
+1 (732)
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 350 Carter Road
  • Princeton, NJ 08540
  • United States
+1 (732)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NJ Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 12-Aug-2025 $10M In Progress Generating Revenue
2. Merger/Acquisition 20-Dec-2024 Completed Generating Revenue
1. Seed Round 09-Mar-2023 $5.62M $5.62M Completed Generating Revenue
To view NJ Bio’s complete valuation and funding history, request access »

NJ Bio Patents

NJ Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025222127-A2 Topoisomerase inhibitors, antibody drug conjugate linkers, methods of making, and methods of use thereof Pending 19-Apr-2024
EP-4720075-A1 Topoisomerase inhibitors, methods of making, and methods of use thereof Pending 26-May-2023
US-20260315612-A1 Topoisomerase inhibitors, methods of making, and methods of use thereof Pending 26-May-2023
WO-2024248944-A1 Topoisomerase inhibitors, methods of making, and methods of use thereof Inactive 26-May-2023
EP-4558506-A1 Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells Pending 22-Jul-2022 C07D491/22
To view NJ Bio’s complete patent history, request access »

NJ Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NJ Bio Acquisitions (1)

NJ Bio’s most recent deal was a Merger/Acquisition with L2P Research. The deal was made on 06-Nov-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
L2P Research 06-Nov-2025 Merger/Acquisition Drug Discovery
To view NJ Bio’s complete acquisitions history, request access »

NJ Bio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
L2P Research Annville, PA 2015

NJ Bio FAQs

  • When was NJ Bio founded?

    NJ Bio was founded in 2018.

  • Where is NJ Bio headquartered?

    NJ Bio is headquartered in Princeton, NJ.

  • What is the size of NJ Bio?

    NJ Bio has 135 total employees.

  • What industry is NJ Bio in?

    NJ Bio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is NJ Bio a private or public company?

    NJ Bio is a Private company.

  • What is NJ Bio’s current revenue?

    The current revenue for NJ Bio is .

  • How much funding has NJ Bio raised over time?

    NJ Bio has raised $5.62M.

  • When was NJ Bio acquired?

    NJ Bio was acquired on 12-Aug-2025.

  • Who acquired NJ Bio?

    NJ Bio was acquired by Cohance Lifesciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process